Timothy Aliff

2.0k total citations · 1 hit paper
8 papers, 1.6k citations indexed

About

Timothy Aliff is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Timothy Aliff has authored 8 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Timothy Aliff's work include Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (1 paper). Timothy Aliff is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (1 paper). Timothy Aliff collaborates with scholars based in United States. Timothy Aliff's co-authors include David G. Pfister, Christopher G. Azzoli, R. Smith, David Trent, Giuseppe Giaccone, Daniel T. Milton, Joan H. Schiller, William Pao, Julie R. Brahmer and Thomas J. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Investigational New Drugs.

In The Last Decade

Timothy Aliff

8 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

2009 752 citations Christopher G. Azzoli, Sherman Baker et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Aliff United States	8	1.0k	908	282	187	172	8	1.6k
J Maestre Spain	14	1.6k 1.6×	1.1k 1.2×	706 2.5×	228 1.2×	114 0.7×	26	2.5k
Yuka Fujita Japan	21	1.2k 1.2×	1.2k 1.3×	321 1.1×	146 0.8×	67 0.4×	77	1.8k
Jin Ho Baek South Korea	21	436 0.4×	626 0.7×	266 0.9×	126 0.7×	76 0.4×	100	1.4k
N Horikoshi Japan	18	1.0k 1.0×	1.4k 1.6×	303 1.1×	116 0.6×	32 0.2×	82	2.0k
C. Cripps Canada	18	401 0.4×	712 0.8×	203 0.7×	149 0.8×	33 0.2×	54	1.2k
Enzo Maria Ruggeri Italy	22	535 0.5×	681 0.8×	274 1.0×	89 0.5×	32 0.2×	103	1.4k
M. Clerici Italy	15	1.2k 1.2×	1.4k 1.5×	495 1.8×	110 0.6×	33 0.2×	33	2.1k
Charalambos Kouroussis Greece	18	752 0.8×	1.0k 1.2×	264 0.9×	173 0.9×	18 0.1×	49	1.5k
Hideyuki Ohshimo Japan	13	709 0.7×	1.0k 1.1×	284 1.0×	99 0.5×	23 0.1×	17	1.4k
Laurent Bastit France	10	346 0.3×	647 0.7×	128 0.5×	59 0.3×	47 0.3×	19	1.1k

Countries citing papers authored by Timothy Aliff

Since Specialization

Citations

This map shows the geographic impact of Timothy Aliff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Aliff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Aliff more than expected).

Fields of papers citing papers by Timothy Aliff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Aliff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Aliff. The network helps show where Timothy Aliff may publish in the future.

Co-authorship network of co-authors of Timothy Aliff

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Aliff. A scholar is included among the top collaborators of Timothy Aliff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Aliff. Timothy Aliff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Azzoli, Christopher G., Sarah Temin, Timothy Aliff, et al.. (2011). 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 29(28). 3825–3831. 234 indexed citations

2.

Azzoli, Christopher G., Sherman Baker, Sarah Temin, et al.. (2010). [American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].. PubMed. 13(3). 171–89. 48 indexed citations

3.

Azzoli, Christopher G., Sherman Baker, Sarah Temin, et al.. (2009). American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 27(36). 6251–6266. 752 indexed citations breakdown →

4.

Fury, Matthew G., Richard J. Wong, Ennapadam Venkatraman, et al.. (2006). A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers. Investigational New Drugs. 25(2). 165–172. 62 indexed citations

5.

Pfister, David G., Yungpo Bernard Su, Dennis H. Kraus, et al.. (2006). Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm. Journal of Clinical Oncology. 24(7). 1072–1078. 233 indexed citations

6.

Aliff, Timothy, P. Maslak, Joseph G. Jurcic, et al.. (2003). Refractory Aspergillus pneumonia in patients with acute leukemia. Cancer. 97(4). 1025–1032. 172 indexed citations

7.

Weiss, Mark A., P. Maslak, Joseph G. Jurcic, et al.. (2003). Pentostatin and Cyclophosphamide: An Effective New Regimen in Previously Treated Patients With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 21(7). 1278–1284. 80 indexed citations

8.

Weiss, Mark A., Timothy Aliff, Martin S. Tallman, et al.. (2002). A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer. 95(3). 581–587. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact